Xian Ping Lu
Amministratore Delegato presso SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
Patrimonio netto: 67 M $ in data 30/04/2024
Posizioni attive di Xian Ping Lu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Amministratore Delegato | 24/03/2018 | - |
| Presidente | 24/03/2018 | - | |
| Fondatore | 21/03/2001 | - | |
| Direttore/Membro del Consiglio | 21/03/2001 | 24/03/2018 | |
| Direttore Tecnico/Scientifico/R&S | 21/03/2001 | 01/01/2020 | |
| Presidente | 21/03/2001 | 24/03/2018 |
Storia della carriera di Xian Ping Lu
Precedenti posizioni note di Xian Ping Lu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Galderma Research & Development SNC
 Galderma Research & Development SNC Pharmaceuticals: MajorHealth Technology Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France. | Corporate Officer/Principal | - | - |
Maxia Pharmaceuticals, Inc.
 Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Fondatore | - | - |
Formazione di Xian Ping Lu
| Sichuan University | Undergraduate Degree |
| Peking Union Medical College | Graduate Degree |
Statistiche
Distribuzione geografica
| Cina | 4 |
| Stati Uniti | 2 |
| Francia | 2 |
Posizioni
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
Maxia Pharmaceuticals, Inc.
Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Commercial Services |
Galderma Research & Development SNC
Galderma Research & Development SNC Pharmaceuticals: MajorHealth Technology Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France. | Health Technology |
- Borsa valori
- Insiders
- Xian Ping Lu
- Esperienza
